119 related articles for article (PubMed ID: 21144970)
21. BNP-guided therapy for heart failure.
Piña IL; O'Connor C
JAMA; 2009 Jan; 301(4):432-4. PubMed ID: 19176447
[No Abstract] [Full Text] [Related]
22. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
Zieliński T
Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435
[No Abstract] [Full Text] [Related]
23. Prognosis in heart failure with a normal ejection fraction.
Cleland JG; Taylor J; Tendera M
N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
[No Abstract] [Full Text] [Related]
24. Paediatric heart failure trials...and tribulations.
Shaddy RE
Cardiol Young; 2007 Aug; 17(4):354-5. PubMed ID: 17572938
[No Abstract] [Full Text] [Related]
25. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
[TBL] [Abstract][Full Text] [Related]
26. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure.
Huang DJ
Chin Med J (Engl); 2009 Mar; 122(6):608-9. PubMed ID: 19323919
[No Abstract] [Full Text] [Related]
27. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
28. [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure].
Tabak'ian EA; Zaruba AIu; Rogoza AN; Ataullakhanova DM; Kukharchuk VV
Ter Arkh; 2010; 82(8):24-9. PubMed ID: 20873241
[TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic peptide as a marker of heart failure: Not so specific after all?
Marshall W; Orlando R
Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197
[No Abstract] [Full Text] [Related]
30. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
31. [Heart failure in the elderly and NT-proBNP].
Castellote Varona FJ; Atienza Morales MP
Rev Esp Geriatr Gerontol; 2009; 44(5):290-1; author reply 291-2. PubMed ID: 19656590
[No Abstract] [Full Text] [Related]
32. Response to "Getting the right message".
Januzzi JL; Camargo CA; Tung R
Ann Emerg Med; 2007 Mar; 49(3):381-3; discussion 383; author reply 384. PubMed ID: 17317512
[No Abstract] [Full Text] [Related]
33. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
[No Abstract] [Full Text] [Related]
34. [Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations].
Latini R; Masson S
Ital Heart J Suppl; 2000 Aug; 1(8):1068-9. PubMed ID: 10993019
[No Abstract] [Full Text] [Related]
35. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
Lindstedt G
Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
[No Abstract] [Full Text] [Related]
36. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
Januzzi JL; Bayes-Genis A
Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
[TBL] [Abstract][Full Text] [Related]
37. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
Daly MG; Frampton CM; Troughton RW
J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
[No Abstract] [Full Text] [Related]
38. Serum biomarkers for heart failure.
Jarolim P
Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
[TBL] [Abstract][Full Text] [Related]
39. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
Gallegos PJ; Maclaughlin EJ; Haase KK
Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
[TBL] [Abstract][Full Text] [Related]
40. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
Dahlström U
Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
